CXCR4 Blockade Attenuates Hyperoxia-Induced Lung Injury in Neonatal Rats
Authors:
- 21 March 2015
- journal article
- research article
- Published by S. Karger AG in Neonatology
- Vol. 107 (4) , 304-311
Abstract
Background: Lung inflammation is a key factor in the pathogenesis of bronchopulmonary dysplasia (BPD). Stromal-derived factor-1 (SDF-1) and its receptor chemokine receptor 4 (CXCR4) modulate the inflammatory response. It is not known if antagonism of CXCR4 alleviates lung inflammation in neonatal hyperoxia-induced lung injury. Objective: We aimed to determine whether CXCR4 antagonism would attenuate lung injury in rodents with experimental BPD by decreasing pulmonary inflammation. Methods: Newborn rats exposed to normoxia (room air, RA) or hyperoxia (FiO2 = 0.9) from postnatal day 2 (P2) to P16 were randomized to receive the CXCR4 antagonist, AMD3100 or placebo (PL) from P5 to P15. Lung alveolarization, angiogenesis and inflammation were evaluated at P16. Results: Compared to the RA pups, hyperoxic PL pups had a decrease in alveolarization, reduced lung vascular density and increased lung inflammation. In contrast, AMD3100-treated hyperoxic pups had improved alveolarization and increased angiogenesis. This improvement in lung structure was accompanied by a decrease in the macrophage and neutrophil counts in the bronchoalveolar lavage fluid and reduced lung myeloperoxidase activity. Conclusion: CXCR4 antagonism decreases lung inflammation and improves alveolar and vascular structure in neonatal rats with experimental BPD. These findings suggest a novel therapeutic strategy to alleviate lung injury in preterm infants with BPD.Keywords
This publication has 24 references indexed in Scilit:
- Matrix Metalloproteinase-9 and Stromal Cell-Derived Factor-1 Act Synergistically to Support Migration of Blood-Borne Monocytes into the Injured Spinal CordThe Journal of Neuroscience, 2011
- Characterization of fibroblasts recruited from bone marrow-derived precursor in neonatal bronchopulmonary dysplasia miceJournal of Applied Physiology, 2011
- CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarctionProceedings of the National Academy of Sciences, 2010
- Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the Protean Effects of “Selective” AntagonistsJournal of Biological Chemistry, 2009
- Inhibition of the SDF-1/CXCR4 Axis Attenuates Neonatal Hypoxia-Induced Pulmonary HypertensionCirculation Research, 2009
- Role of the SDF-1/CXCR4 Axis in the Pathogenesis of Lung Injury and FibrosisAmerican Journal of Respiratory Cell and Molecular Biology, 2007
- Pulmonary Stromal-Derived Factor-1 Expression and Effect on Neutrophil Recruitment during Acute Lung InjuryThe Journal of Immunology, 2007
- Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasiaAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- AMD3100, a CxCR4 Antagonist, Attenuates Allergic Lung Inflammation and Airway HyperreactivityThe American Journal of Pathology, 2002
- Embryonic Expression and Function of the Chemokine SDF-1 and Its Receptor, CXCR4Developmental Biology, 1999